secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0000898432-23-000117
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellevue Life Sciences Acquisition Corp. closes IPO and full over-allotment, raising $69M
--------------------------------------------------------------------------------

- IPO of 6M units at $10/unit closed Feb 14, 2023; over-allotment of 900K units exercised in full, total 6.9M units.
- Gross proceeds of $69M from IPO and over-allotment; $70.2M placed in trust account including private placement.
- Appointed five independent directors: Dr. Steven G. Reed (Chairman), Dr. In Chul Chung, Dr. Rad Roberts, Mr. Hosun Euh, Mr. Jin Whan Park.
- Units trade on Nasdaq under BLACU; common, warrants, rights under BLAC, BLACW, BLACR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000089843223000117/0000898432-23-000117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000089843223000117/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0000898432-23-000117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer